What Orbicular Pharmaceutical Technologies does
Founded in 2010, Orbicular Pharmaceutical Technologies operates in Health Tech offering specialty pharmaceutical solutions through the development of niche and complex dosage forms for licensing to global partners. Based in Hyderabad, India, the company features a state-of-the-art research facility and a strong team of over 300 scientists dedicated to delivering highly complex pharmaceutical products. Orbicular’s expertise includes developing generics and 505(b)(2) products with advanced technology, including nano-suspensions and long-acting injectables. The company aims to create value-generating partnerships within the global pharmaceutical sector, focusing on products that present significant entry barriers and market potential.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Orbicular Pharmaceutical Technologies yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.